ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.
What’s Going On With Canopy Growth Stock Today?
Canopy Growth shares are trading lower Monday after the company announced Institutional Shareholder Services (ISS) has recommended that Canopy shareholders vote to approve the creation of exchangeable shares to further the advancement of Canopy USA.
